The effect of inorganic cations Ca2+ and Al3+ on the release rate of propranolol hydrochloride from sodium carboxymethylcellulose matrices

Daru

Volumn 17, Issue 2, 2009, Pages 131-138

  Mohammadi, G ^a,b   Barzegar Jalali, M ^a,c   Siahi Shadbad, M ^a   Azarmi, S ^a,d   Barzegar Jalali, A ^e   Rasekhian, M ^a   Adibkia, K ^a,f   Danesh Bahreini, M ^a,g   Kiafar, F ^a,d   Zare, M ^a,c   Raeesi, R ^a,c   Hosseini Nasab, S S ^a,c  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b KERMANSHAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e School of Medicine   (Iran)

^f TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^g SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Ca2+ and Al3+; Cross Linking; Matrix; Propranolol hydrochloride; Sodium carboxymethylcellulose

Indexed keywords

ALUMINUM CHLORIDE; CALCIUM CHLORIDE; CARBOXYMETHYLCELLULOSE; MAGNESIUM STEARATE; METAL ION; PROPRANOLOL; TYLOPUR C; UNCLASSIFIED DRUG;

ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; DRUG FORMULATION; DRUG SOLUBILITY; SUSTAINED DRUG RELEASE; TABLET MATRIX;

EID: 68949113486     PISSN: 15608115     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Bolourchian N, Dadashzadeh S. pH-independent release of propranolol hydrochloride from HPMCbased matrices using organic acids. Daru 2008; 16: 136-142.
2. Colombo P, Bettini R, Santi P, Peppas NA. Swellable matrices for controlled drug delivery: gel-layer behavior, mechanism and optimal performance. Pharmaceut. Sci. Technol. Today, 2000; 3: 198-204.
3. Mehuys E, Remon JP, Korst A, Bortel LV, Mols R, Augustijns P, Porter C, Vervaet C. Human bioavailability of propranolol from a matrix-in-cylinder system with a HPMC-Gelucire core. J Control Release 2005; 107: 523-536. (Pubitemid 41393359)
4. Siahi MR, Barzegar-Jalali M, Monajjemzadeh F, Ghaffari F, Azarmi S. Design and evaluation of 1-and 3-layer matrices of verapamil hydrochloride for sustaining its release. AAPS PharmSciTech 2005; 6: Article 77. E626-E632. (Pubitemid 41823818)
5. Hayashi T, Kanbea H, Okadaa M, Suzuki M, Ikeda Y, Onuki Y, Kaneko T, Sonobe T. Formulation study and drug release mechanism of a new theophylline sustained-release preparation. Int. J. Pharm 2005; 304: 91-101. (Pubitemid 41427653)
6. Stavropoulou A, Papadkostaki KG, Sanopoulou M. Experimental and theoretical study of the release kinetics of propranolol hydrochloride from PVA matrices. J. Control. Release 2005; 101: 313-315.
7. Bodea A, Leucuta SE, Optimization of propranolol hydrochloride sustained release pellets using a factorial design. Int. J. Pharm 1997; 154: 49-57. (Pubitemid 27326819)
8. Nokhodchi A, Norouzi-Sani S, Siahi-Shadbad MR, Lotfipoor F, Saeedi M. The effect of various surfactants on the release rate of propranolol hydrochloride from hydroxypropylmethylcellulose (HPMC)-Eudragit matrices. Eur. J. Pharm. Biopharm 2002; 54: 349-356.
9. Barzegar-Jalali M, Adibkia K, Mohammadi G, Zeraati M, Aghaee Ghare Bolagh B, Nokhodchi A. Propranolol hydrochloride osmotic capsule with controlled onset of release. Drug Delivery 2007; 14: 461-468. (Pubitemid 350125740)
10. Sajadi Tabassi SA, Razavi N. Preparation and characterization of albumin microspheres encapsulated with propranolol HCl. Daru 2003; 11: 137-141. (Pubitemid 38715146)
11. Rekhi GS, Jambhekar SS. Bioavailability and in-vitro/in-vivo correlation for propranolol hydrochloride extended-release bead products prepared using aqueous polymeric dispersions. J. Pharm. Pharmacol 1996; 48: 1276-1284.
12. Mutasem O, Wissam Nasser T, Ardakani A, Al-khatib H. Sodium lauryl sulfate impedes drug release from zinc-crosslinked alginate beads: Switching from enteric coating release into biphasic profiles. Int. J. Pharm 2008; 350: 291-300.
13. Halder A, Maiti S, Sa B. Entrapment efficiency and release characteristics of polyethyleneiminetreated or -untreated calcium alginate beads loaded with propranolol-resin complex. Int. J. Pharm 2008; 350: 291-300. (Pubitemid 41244818)
14. Gonzalez-Rodriguez M. L, Holgado M. A, Sanchez-Lafuente C, Rabasco A, Fini M, A. Alginate/chitosan particulate systems for sodium diclofenac release. Int. J. Pharm 2002; 232: 225-234.
15. Azarmi S, Valizadeh H, Barzegar - Jalali M, Lobenberg R. In situ crosslinking of polyanionic polymers to sustain the drug release of acetazolamide tablets. Pharm. Ind 2003; 65: 877-881.
16. Barzegar-Jalali M, Siahi Shadbad MR, Azarmi S, Barzegar-Jalali A, Mohammadi G, Adibkia K. Study on the release of acetazolamide from matrices containing tragacanth and acacia gums. Pharm. Scis. (Iran) 2007; Winter: 21-28.
17. th edition. Pharmaceutical Press, London, 2005. p 989
18. USP29 NF 24, United States Pharmacopeial Convention, INC.; Rockville, 2006, 2927-2929.
19. Khan KA. Concept of dissolution efficiency. J. Pharm. Pharmacol 1975; 27: 48-49.
20. Costa P, Lobo JMS. Modeling and comparison of dissolution profiles. Eur. J. Pharm. Sci 2001; 13: 123-133.
21. Al-Musa S, Abu Fara D, Badwan A.A. Evaluation of parameters involved in preparation and release of drug loaded in crosslinked matrices of alginate. J. Control. Release 1999; 57: 223-232. (Pubitemid 29073438)
22. George M, Emilia Abraham T. Polyionic hydrocolloids for the intestinal delivery of protein drugs: Alginate and chitosan-a review. J. Control. Release 2006; 114:1-14. (Pubitemid 44131680)